Advertisement

Topics

Aperiomics Launches New Website

14:51 EDT 2 Aug 2017 | Virginia Biotechnology

Aperiomics is one of the rising stars of the biotech industry. The company is growing quickly and has drawn attention not only of the medical industry but investors as well. Over the first six months of 2017, Aperiomics grew its customer base ten-fold. Revenue over the same period alone was higher than the entirety of the company’s revenue since it started in 2014. Aperiomics has received more than $1.6 million in grants from the National Science Foundation – the latest, a grant to further develop its pathogen identification platform.

The new Aperiomics website provides specific information on services for clinicians, patients and researchers:

  • For clinicians, Aperiomics solves inadequate pathogen testing by using deep next-generation sequencing and the Aperiomics Microbial Database™ (the world’s largest collection of pathogens) to test for everything instead of only a few things at a time.

  • For patients, Aperiomics can help their doctors provide faster wellness through more accurate identification of the causes of infectious diseases.

  • For researchers, next-generation sequencing and bioinformatic services can be customized for all pathogen testing and microbiome characterization work. Aperiomics has worked with many organizations to support genetic monitoring, biosurveillance, pathogen identification, microbiome characterization and quality monitoring programs.


Among customers that Aperiomics has helped are hundreds of patients for whom doctors could not find a solution to their illnesses until their samples were analyzed by Aperiomics to detect which pathogens were responsible. For some it was a life-death issue. Americans spend $200-250 billion per year on medical diagnostic testing according to the American College of Physicians. Much of that testing uses old technology and guesswork, leading to wasted time, money and chronic infection.

“Aperiomics is at the forefront of a very exciting worldwide expansion of technology in medicine,” said company CEO Dr. Crystal Icenhour. “Because of our powerful technology and the expert team we have in place, medical professionals and patients put their confidence in Aperiomics to find answers that no one else can find.”

Original Article: Aperiomics Launches New Website

NEXT ARTICLE

More From BioPortfolio on "Aperiomics Launches New Website"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...